BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Genetown

  PAREXEL International Ethnobridging Experts Introduce New Edition of Accelerating Global Drug Development

  September 29, 2011

   · 

  6 min read
• Med Epad to Launch Acclaimed Complete Mobile Healthcare Solution at Healthcare Efficiency Through Technology Expo 2011

  September 29, 2011

   · 

  4 min read
• Business

  Defense Advanced Research Projects Agency Extends Contract with AnaptysBio, Inc. to Generate Additional High Affinity Thermally Stable Antibodies

  September 29, 2011

   · 

  1 min read
• BioCapital

  Biotechnology Industry Organization (BIO) Welcomes Mississippi Biotechnology Association to Industry Council

  September 29, 2011

   · 

  1 min read
• Business

  BioMarin Pharmaceutical Inc. to Host Third Quarter 2011 Financial Results Conference Call and Webcast on Thursday, October 27 at 5:00 p.m. ET

  September 29, 2011

   · 

  2 min read
• Genetown

  Charles River Laboratories (Massachusetts) Release: Scientific Consortium Awarded Knockout Mouse Project Grant from the National Institutes of Health (NIH)

  September 29, 2011

   · 

  1 min read
• Drug Development

  Otonomy, Inc. Presents Positive New Findings From Phase 1b Study of OTO-104 in Meniere’s Disease at International Conference

  September 29, 2011

   · 

  6 min read
• Pharm Country

  Janssen Biotech Inc. Release: Casey Abrams Announces Finalists in National Inflammatory Bowel Disease Awareness Campaign and Calls on America to Vote

  September 29, 2011

   · 

  5 min read
• Business

  Synthetic Genomics, Inc. Hires Vaccine Executive Sammy J. Farah as President

  September 29, 2011

   · 

  2 min read
• Drug Development

  Telik, Inc. Announces Publication in the Journal Cancer of a Phase 2 Randomized Multicenter Study of Two Extended Dosing Schedules of Oral Ezatiostat in Low to Intermediate-1 Risk Myelodysplastic Syndrome

  September 29, 2011

   · 

  3 min read